L, K., MS, F., CH, P., G, E., HP, H., DH, M., . . . Hartung, H. (2007). Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: A 3-year follow-up analysis of the BENEFIT study. Lancet, 370(9585), 389. https://doi.org/10.1016/s0140-6736(07)61194-5
Chicago Style (17th ed.) CitationL, Kappos, et al. "Effect of Early Versus Delayed Interferon Beta-1b Treatment on Disability After a First Clinical Event Suggestive of Multiple Sclerosis: A 3-year Follow-up Analysis of the BENEFIT Study." Lancet 370, no. 9585 (2007): 389. https://doi.org/10.1016/s0140-6736(07)61194-5.
MLA (9th ed.) CitationL, Kappos, et al. "Effect of Early Versus Delayed Interferon Beta-1b Treatment on Disability After a First Clinical Event Suggestive of Multiple Sclerosis: A 3-year Follow-up Analysis of the BENEFIT Study." Lancet, vol. 370, no. 9585, 2007, p. 389, https://doi.org/10.1016/s0140-6736(07)61194-5.